These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25611585)

  • 21. Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.
    Russell RK; Ip B; Aldhous MC; MacDougall M; Drummond HE; Arnott ID; Gillett PM; McGrogan P; Weaver LT; Bisset WM; Mahdi G; Wilson DC; Satsangi J
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):161-7. PubMed ID: 19179877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
    Hadrich I; Vandewalle P; Cheikhrouhou F; Makni F; Krichen MS; Sendid B; Standaert-Vitse A; Ayadi A; Poulain D
    Scand J Gastroenterol; 2007 Jun; 42(6):717-25. PubMed ID: 17505994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease].
    Le Goff C; Chapelle JP; Lutteri L
    Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this setting.
    Sendid B; Jawhara S; Sarter H; Maboudou P; Thierny C; Gower-Rousseau C; Colombel JF; Poulain D
    Virulence; 2018; 9(1):1224-1229. PubMed ID: 30027793
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease.
    Seibold F; Konrad A; Flogerzi B; Seibold-Schmid B; Arni S; Jüliger S; Kun JF
    Gastroenterology; 2004 Oct; 127(4):1076-84. PubMed ID: 15480986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease.
    Kotze LM; Nisihara RM; Utiyama SR; Kotze PG; Theiss PM; Olandoski M
    Arq Gastroenterol; 2010; 47(3):242-5. PubMed ID: 21140083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
    Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
    Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease.
    Konrad A; Rütten C; Flogerzi B; Styner M; Göke B; Seibold F
    Inflamm Bowel Dis; 2004 Mar; 10(2):97-105. PubMed ID: 15168808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D
    Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
    Cruyssen BV; Peeters H; Hoffman IE; Laukens D; Coucke P; Marichal D; Cuvelier C; Remaut E; Veys EM; Mielants H; De Vos M; De Keyser F
    Clin Exp Immunol; 2005 May; 140(2):354-9. PubMed ID: 15807862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease.
    Eser A; Papay P; Primas C; Pernicka E; Harrer M; Dejaco C; Novacek G; Lichtenberger C; Angelberger S; Kazemi L; Mikulits A; Vogelsang H; Reinisch W
    Aliment Pharmacol Ther; 2012 Jan; 35(2):292-9. PubMed ID: 22146122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
    Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A
    Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease.
    Oshitani N; Hato F; Matsumoto T; Jinno Y; Sawa Y; Hara J; Nakamura S; Seki S; Arakawa T; Kitano A; Kitagawa S; Kuroki T
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1400-3. PubMed ID: 11197050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.
    Giaffer MH; Clark A; Holdsworth CD
    Gut; 1992 Aug; 33(8):1071-5. PubMed ID: 1398231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.
    Kim YS; Kim YH; Kim WH; Kim JS; Park YS; Yang SK; Ye BD; Jang BI; Jung SA; Jeen YT; Cheon JH; Choi YS; Choi JH; Kim BJ; Choi CH; Han DS
    Clin Chim Acta; 2011 Aug; 412(17-18):1527-32. PubMed ID: 21575618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients.
    Shafran I; Piromalli C; Decker JW; Sandoval J; Naser SA; El-Zaatari FA
    Dig Dis Sci; 2002 Sep; 47(9):2079-81. PubMed ID: 12353858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease].
    Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M
    Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.